PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple Myeloma.
Saved in:
| Title: | PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple Myeloma. |
|---|---|
| Authors: | Schavgoulidze A; Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Cui J; 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA, United States., Encinas J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., United States., Favasuli VK; Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy., Talluri S; DFCI, Boston, Massachusetts, United States., Mahéo S; IUCT, TOULOUSE, France., Cerutti C; Institut Universitaire du Cancer de Toulouse-Oncopole, 31100, France., Shammas MA; Dana Farber Cancer Institute, Boston, Massachusetts, United States., Primo D; Vivia Biotech, Madrid, Spain., Vicente C; University of Navarra, Pamplona, Spain., Larrayoz M; CIMA, Pamplona, Spain., Martínez-Climent JA; Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain., Anderson KC; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Aktas Samur A; Dana Farber Cancer Institution, Boston, Massachusetts, United States., Samur MK; Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts, United States., Avet-Loiseau H; University Hospital, Sarzeau, France., Corre J; Unité de Genomique du Myélome, IUC- T Oncopole, TOULOUSE, France., Munshi NC; Dana Farber Cancer Institute, Boston, Massachusetts, United States., Fulciniti M; Dana Farber Cancer Institute, Boston, Massachusetts, United States. |
| Source: | Blood [Blood] 2026 Jun 03. Date of Electronic Publication: 2026 Jun 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42237635 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple Myeloma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Schavgoulidze+A%22">Schavgoulidze A</searchLink>; Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Cui+J%22">Cui J</searchLink>; 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA, United States.<br /><searchLink fieldCode="AU" term="%22Encinas+J%22">Encinas J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., United States.<br /><searchLink fieldCode="AU" term="%22Favasuli+VK%22">Favasuli VK</searchLink>; Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy.<br /><searchLink fieldCode="AU" term="%22Talluri+S%22">Talluri S</searchLink>; DFCI, Boston, Massachusetts, United States.<br /><searchLink fieldCode="AU" term="%22Mahéo+S%22">Mahéo S</searchLink>; IUCT, TOULOUSE, France.<br /><searchLink fieldCode="AU" term="%22Cerutti+C%22">Cerutti C</searchLink>; Institut Universitaire du Cancer de Toulouse-Oncopole, 31100, France.<br /><searchLink fieldCode="AU" term="%22Shammas+MA%22">Shammas MA</searchLink>; Dana Farber Cancer Institute, Boston, Massachusetts, United States.<br /><searchLink fieldCode="AU" term="%22Primo+D%22">Primo D</searchLink>; Vivia Biotech, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Vicente+C%22">Vicente C</searchLink>; University of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Larrayoz+M%22">Larrayoz M</searchLink>; CIMA, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez-Climent+JA%22">Martínez-Climent JA</searchLink>; Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Anderson+KC%22">Anderson KC</searchLink>; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.<br /><searchLink fieldCode="AU" term="%22Aktas+Samur+A%22">Aktas Samur A</searchLink>; Dana Farber Cancer Institution, Boston, Massachusetts, United States.<br /><searchLink fieldCode="AU" term="%22Samur+MK%22">Samur MK</searchLink>; Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts, United States.<br /><searchLink fieldCode="AU" term="%22Avet-Loiseau+H%22">Avet-Loiseau H</searchLink>; University Hospital, Sarzeau, France.<br /><searchLink fieldCode="AU" term="%22Corre+J%22">Corre J</searchLink>; Unité de Genomique du Myélome, IUC- T Oncopole, TOULOUSE, France.<br /><searchLink fieldCode="AU" term="%22Munshi+NC%22">Munshi NC</searchLink>; Dana Farber Cancer Institute, Boston, Massachusetts, United States.<br /><searchLink fieldCode="AU" term="%22Fulciniti+M%22">Fulciniti M</searchLink>; Dana Farber Cancer Institute, Boston, Massachusetts, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2026 Jun 03. <i>Date of Electronic Publication: </i>2026 Jun 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42237635 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/blood.2026033819 Languages: – Code: eng Text: English Titles: – TitleFull: PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple Myeloma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schavgoulidze A – PersonEntity: Name: NameFull: Cui J – PersonEntity: Name: NameFull: Encinas J – PersonEntity: Name: NameFull: Favasuli VK – PersonEntity: Name: NameFull: Talluri S – PersonEntity: Name: NameFull: Mahéo S – PersonEntity: Name: NameFull: Cerutti C – PersonEntity: Name: NameFull: Shammas MA – PersonEntity: Name: NameFull: Primo D – PersonEntity: Name: NameFull: Vicente C – PersonEntity: Name: NameFull: Larrayoz M – PersonEntity: Name: NameFull: Martínez-Climent JA – PersonEntity: Name: NameFull: Anderson KC – PersonEntity: Name: NameFull: Aktas Samur A – PersonEntity: Name: NameFull: Samur MK – PersonEntity: Name: NameFull: Avet-Loiseau H – PersonEntity: Name: NameFull: Corre J – PersonEntity: Name: NameFull: Munshi NC – PersonEntity: Name: NameFull: Fulciniti M IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 06 Text: 2026 Jun 03 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1528-0020 Titles: – TitleFull: Blood Type: main |
| ResultId | 1 |